

* Q1 non-GAAP earnings per share $2.84 vs f'cast $2.60 * Revenue up 11 percent to $1.49 billion * Vyvanse sales up 17 percent to $417 million * Shares...


Shire surged after reporting that earnings rose 20% in the first quarter as sales at the Dublin-headquartered drug company overcame a sharp drop in it...


Earnings at Shire surged 20% in the first quarter as sales at the Dublin-headquartered drug company overcame a sharp drop in its Intuniv attention def...


LONDON, April 30 (Reuters) - Pharmaceutical company Shire posted a better-than-expected 20 percent rise in first-quarter earnings on Thursday, booste...